ERK implication in cell cycle regulation.
By J. Chambard, R. Lefloch, J. Pouysségur, P. Lenormand. Biochimica et Biophysica Acta, 2007
784 citations recorded by the source corpus.
Subfields: Molecular Biology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/493ab5c531b71f7b1b6fcd1f9610753da0c98f51
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- J. Mouw
- Michael W. Pickup
- Ping Wee
- Valerie M. Weaver
- Zhixiang Wang
- Kevin W. Eliceiri
- David Inman
- P. Keely
In Pathology and Forensic Medicine
Citations in the corpus
- Matrix density-induced mechanoregulation of breast cell phenotype, signaling, and gene expression through a FAK-ERK linkage (2009, positive): “In addition, ERK is predicted to regulate TFs associated with earlier phases of the cell cycle (such as E2F, c-Myb, Elk-1; (Chambard et al., 2007;Oh & Reddy, 1999)), consistent with our finding that ERK inhibition resulted in reduced expression of genes associated with each phase of the cell cycle…”
- The extracellular matrix modulates the hallmarks of cancer (2014, positive): “Indeed, in response to a stiffened matrix, cells elevate Fak phosphorylation and stimulate Erk, PI3K and Rac, which accelerates cell cycle progression through increased expression of cyclin D1 [7,32–34].”
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways (2017, background): “Importantly, the activated ERK MAPK and AKT pathways also inhibit various pro-apoptotic proteins, including BIM, Caspase-9, and BAD.”